Rapamycin (Natürlich): Sicherheit — comprehensive data and statistics for supplements. In 2024 a value of Germany was recorded for 12,3 .. This visualization presents the development from 2014 to 2024 and compares Germany with other European countries based on data from World Bank. Explore trends, extreme values and international differences.
Live Data
Rapamycin (Natürlich): Safety
Live Data
Rapamycin (Natürlich): Safety
No data available.
📋 Data table (4 countries, 10 years)
| Year | Germany | Spain | France | Italy |
|---|---|---|---|---|
| 2015 | 10,9 | 9,2 | 11,5 | 8,8 |
| 2016 | 11 | 8,9 | 11,6 | 8,7 |
| 2017 | 11,1 | 9,0 | 11,4 | 8,7 |
| 2018 | 11,2 | 9,1 | 11,3 | 8,7 |
| 2019 | 11,4 | 9,2 | 11,2 | 8,6 |
| 2020 | 12,5 | 10,8 | 12,1 | 9,6 |
| 2021 | 12,7 | 10,3 | 12,2 | 9,3 |
| 2022 | 12,4 | 9,7 | 11,8 | 8,9 |
| 2023 | 11,7 | 9,2 | 11,5 | 8,4 |
| 2024 | 12,3 | – | 11,5 | 8,4 |
Source: World Bank. Values rounded. All information without guarantee.
📊 Quick overview: Latest values compared
Analysis
The development of Rapamycin (Natürlich): Sicherheit in Germany shows clear dynamics in the period from 2014 to 2024 While the initial value in. was 2014 the indicator reached a value of 10,8, a value of 2024 a value of 12,3. This represents a change of +13.9% (increased).
The highest value was recorded in 2021 with 12,7. The minimum was reached in 2014 with 10,8. The range between the highest and lowest value is therefore 2,0, illustrating the volatility of the indicator in the observation period.
In an international comparison Germany with 12,3 (2024), followed by France (11,5) and Spain (9,2). At the bottom are France (11,5), Spain (9,2)and Italy (8,4). The difference between the highest and lowest value is 3,8.
Overall, Rapamycin (Natürlich): Sicherheit for Germany an upward trend (2014–2024). The data is based on surveys by World Bank and is updated regularly to reflect the latest available values.
Methodology
The data for Rapamycin (Natürlich): Sicherheit comes from World Bank and covers the period 2014–2024. World Bank is an official statistical source that collects data using standardized methods. Values are expressed in the unit „Index" .. These are rounded values that correspond to the original source. All data is loaded server-side and visible in the HTML source code..
Frequently Asked Questions
What is the current value of Rapamycin (Natürlich): Sicherheit?
The most recent value for Germany is 12,3 (as of 2024). The data comes from official surveys by World Bank.
How has Rapamycin (Natürlich): Sicherheit changed over time?
In the period from 2014 to 2024 in Rapamycin (Natürlich): Sicherheit in Germany increased (+13.9%). The value changed from 10,8 to 12,3.
Which country has the highest value for Rapamycin (Natürlich): Sicherheit?
Germany leads with 12,3, followed by France (11,5). In total, 4 countries are compared in the visualization.
What data source is used for Rapamycin (Natürlich): Sicherheit used?
The data for Rapamycin (Natürlich): Sicherheit comes from World Bank. These are official statistical surveys that are updated regularly. and is updated regularly to reflect the latest available values. The methodology follows the standards of the respective organization..
Source: World Bank. Updated: August 2026.
Related Analyses
Show all →Alpha-Liponsäure: Antioxidantien-Markt
Alpha-Liponsäure: Antioxidantien-Markt: Aktuelle Daten und Trends für Europa (2019–2030). Interaktive Charts mit Verglei
AAKG: Performance-Markt Europa 2019–2030
AAKG: Performance-Markt Europa 2019–2030 — Interaktive Datenvisualisierung mit Daten von Eurostat. Supplemente-Vergleich
Acai: Übersicht & Studienlage
Acai: Übersicht & Studienlage — Interaktive Datenvisualisierung mit Daten von Eurostat. Supplemente-Vergleich, Europa-Tr
Amla: Übersicht & Studienlage
Amla: Übersicht & Studienlage — Interaktive Datenvisualisierung mit Daten von Eurostat. Supplemente-Vergleich, Europa-Tr
5-HTP: Übersicht & Studienlage
5-HTP: Übersicht & Studienlage — Interaktive Datenvisualisierung mit Daten von Eurostat. Supplemente-Vergleich, Europa-T
ALA2: Alpha-Liponsäure R-Markt Europa
ALA2: Alpha-Liponsäure R-Markt Europa — Interaktive Datenvisualisierung mit Daten von Eurostat. Supplemente-Vergleich, E
Actein & Menopause: Europäischer Markt
Actein & Menopause: Europäischer Markt — Interaktive Datenvisualisierung mit Daten von Eurostat. Supplemente-Vergleich,
Agaricus blazei: Immunmarkt Europa 2019–2030
Agaricus blazei: Immunmarkt Europa 2019–2030 — Interaktive Datenvisualisierung mit Daten von Eurostat. Supplemente-Vergl